Loading...

You're on the old version of Simply Wall St. We will no longer be supporting this site, so we recommend you switch to our brand new platform.

Sharps Compliance

Nasdaq:SMED
Snowflake Description

Excellent balance sheet with reasonable growth potential.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
SMED
Nasdaq
$118M
Market Cap
  1. Home
  2. US
  3. Healthcare
Company description

Sharps Compliance Corp. provides medical, pharmaceutical, and hazardous waste management services in the United States. The last earnings update was 60 days ago. More info.


Add to Portfolio Compare Print
  • Sharps Compliance has significant price volatility in the past 3 months.
SMED Share Price and Events
7 Day Returns
7.2%
NasdaqCM:SMED
-4%
US Healthcare
-4.1%
US Market
1 Year Returns
101.1%
NasdaqCM:SMED
-4.6%
US Healthcare
-14.9%
US Market
SMED Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Sharps Compliance (SMED) 7.2% 18.8% 69.2% 101.1% 61.7% 9.5%
US Healthcare -4% -12.9% -18.2% -4.6% 12.3% 13.1%
US Market -4.1% -19.1% -23.4% -14.9% 3.5% 14.5%
1 Year Return vs Industry and Market
  • SMED outperformed the Healthcare industry which returned -4.6% over the past year.
  • SMED outperformed the Market in United States of America which returned -14.9% over the past year.
Price Volatility
SMED
Industry
5yr Volatility vs Market

SMED Value

 Is Sharps Compliance undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Sharps Compliance to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Sharps Compliance.

NasdaqCM:SMED Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 3 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 6.1%
Perpetual Growth Rate 10-Year US Government Bond Rate 1.7%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for NasdaqCM:SMED
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year US Govt Bond Rate 1.7%
Equity Risk Premium S&P Global 5.4%
Healthcare Unlevered Beta Simply Wall St/ S&P Global 0.65
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.652 (1 + (1- 21%) (9%))
0.798
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.8
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 1.74% + (0.8 * 5.44%)
6.09%

Discounted Cash Flow Calculation for NasdaqCM:SMED using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Sharps Compliance is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

Note: Free cash flow to equity valuations ignore the company's cash or debt.

NasdaqCM:SMED DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (USD, Millions) Source Present Value
Discounted (@ 6.09%)
2020 -0.10 Analyst x1 -0.09
2021 1.60 Analyst x1 1.42
2022 2.60 Analyst x1 2.18
2023 2.80 Analyst x1 2.21
2024 3.90 Analyst x1 2.90
2025 4.63 Est @ 18.76% 3.25
2026 5.26 Est @ 13.65% 3.48
2027 5.79 Est @ 10.08% 3.61
2028 6.23 Est @ 7.58% 3.66
2029 6.60 Est @ 5.83% 3.65
Present value of next 10 years cash flows $26.00
NasdaqCM:SMED DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2029 × (1 + g) ÷ (Discount Rate – g)
= $6.60 × (1 + 1.74%) ÷ (6.09% – 1.74%)
$154.22
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= $154.22 ÷ (1 + 6.09%)10
$85.37
NasdaqCM:SMED Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= $26.00 + $85.37
$111.37
Equity Value per Share
(USD)
= Total value / Shares Outstanding
= $111.37 / 16.23
$6.86
NasdaqCM:SMED Discount to Share Price
Calculation Result
Value per share (USD) From above. $6.86
Current discount Discount to share price of $7.26
= -1 x ($7.26 - $6.86) / $6.86
-5.8%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

  • The current share price of Sharps Compliance is above its future cash flow value.
Often investors are willing to pay a premium for a company that has a high dividend or the potential for future growth.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Sharps Compliance's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Sharps Compliance's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
NasdaqCM:SMED PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-12-31) in USD $0.06
NasdaqCM:SMED Share Price ** NasdaqCM (2020-04-03) in USD $7.26
United States of America Healthcare Industry PE Ratio Median Figure of 45 Publicly-Listed Healthcare Companies 20.24x
United States of America Market PE Ratio Median Figure of 2,944 Publicly-Listed Companies 12.5x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Sharps Compliance.

NasdaqCM:SMED PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= NasdaqCM:SMED Share Price ÷ EPS (both in USD)

= 7.26 ÷ 0.06

114.93x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Sharps Compliance is overvalued based on earnings compared to the US Healthcare industry average.
  • Sharps Compliance is overvalued based on earnings compared to the United States of America market.
Price based on expected Growth
Does Sharps Compliance's expected growth come at a high price?
Raw Data
NasdaqCM:SMED PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 114.93x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 3 Analysts
54%per year
United States of America Healthcare Industry PEG Ratio Median Figure of 32 Publicly-Listed Healthcare Companies 1.52x
United States of America Market PEG Ratio Median Figure of 2,008 Publicly-Listed Companies 0.91x

*Line of best fit is calculated by linear regression .

NasdaqCM:SMED PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= 114.93x ÷ 54%

2.13x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Sharps Compliance is poor value based on expected growth next year.
Price based on value of assets
What value do investors place on Sharps Compliance's assets?
Raw Data
NasdaqCM:SMED PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-12-31) in USD $1.73
NasdaqCM:SMED Share Price * NasdaqCM (2020-04-03) in USD $7.26
United States of America Healthcare Industry PB Ratio Median Figure of 94 Publicly-Listed Healthcare Companies 2.31x
United States of America Market PB Ratio Median Figure of 5,142 Publicly-Listed Companies 1.22x
NasdaqCM:SMED PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= NasdaqCM:SMED Share Price ÷ Book Value per Share (both in USD)

= 7.26 ÷ 1.73

4.2x

* Primary Listing of Sharps Compliance.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Sharps Compliance is overvalued based on assets compared to the US Healthcare industry average.
X
Value checks
We assess Sharps Compliance's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Healthcare industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Healthcare industry average (and greater than 0)? (1 check)
  5. Sharps Compliance has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

SMED Future Performance

 How is Sharps Compliance expected to perform in the next 1 to 3 years based on estimates from 3 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
54%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Sharps Compliance expected to grow at an attractive rate?
  • Sharps Compliance's earnings growth is expected to exceed the low risk savings rate of 1.7%.
Growth vs Market Checks
  • Sharps Compliance's earnings growth is expected to exceed the United States of America market average.
  • Sharps Compliance's revenue growth is expected to exceed the United States of America market average.
Annual Growth Rates Comparison
Raw Data
NasdaqCM:SMED Future Growth Rates Data Sources
Data Point Source Value (per year)
NasdaqCM:SMED Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 3 Analysts 54%
NasdaqCM:SMED Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 3 Analysts 8.8%
United States of America Healthcare Industry Earnings Growth Rate Market Cap Weighted Average 13.5%
United States of America Healthcare Industry Revenue Growth Rate Market Cap Weighted Average 6.6%
United States of America Market Earnings Growth Rate Market Cap Weighted Average 12.2%
United States of America Market Revenue Growth Rate Market Cap Weighted Average 7.1%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
NasdaqCM:SMED Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 3 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
NasdaqCM:SMED Future Estimates Data
Date (Data in USD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2024-06-30 74 1
2023-06-30 67 1
2022-06-30 62 1
2021-06-30 56 3 2 3
2020-06-30 52 2 1 3
2020-04-04
NasdaqCM:SMED Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2019-12-31 50 1 1
2019-09-30 48 1 1
2019-06-30 44 1 0
2019-03-31 42 2 0
2018-12-31 42 2 0
2018-09-30 41 2 -1
2018-06-30 40 2 -1
2018-03-31 41 1 0
2017-12-31 40 1 0
2017-09-30 38 1 0
2017-06-30 38 -1 -1
2017-03-31 37 0 -2

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Sharps Compliance's earnings are expected to grow significantly at over 20% yearly.
  • Sharps Compliance's revenue is expected to grow by 8.8% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
NasdaqCM:SMED Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 3 Analyst Estimates (S&P Global) See Below

All data from Sharps Compliance Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NasdaqCM:SMED Future Estimates Data
Date (Data in USD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2024-06-30
2023-06-30
2022-06-30
2021-06-30 0.14 0.21 0.10 3.00
2020-06-30 0.09 0.10 0.08 3.00
2020-04-04
NasdaqCM:SMED Past Financials Data
Date (Data in USD Millions) EPS *
2019-12-31 0.06
2019-09-30 0.05
2019-06-30 0.01
2019-03-31 -0.03
2018-12-31 0.00
2018-09-30 -0.04
2018-06-30 -0.04
2018-03-31 0.00
2017-12-31 0.01
2017-09-30 -0.02
2017-06-30 -0.08
2017-03-31 -0.10

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Sharps Compliance will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess Sharps Compliance's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Sharps Compliance has a total score of 4/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

SMED Past Performance

  How has Sharps Compliance performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Sharps Compliance's growth in the last year to its industry (Healthcare).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Sharps Compliance's year on year earnings growth rate was negative over the past 5 years, however the most recent earnings are above average.
  • Sharps Compliance has become profitable in the last year making the earnings growth rate difficult to compare to the 5-year average.
  • Sharps Compliance has become profitable in the last year making it difficult to compare the US Healthcare industry average.
Earnings and Revenue History
Sharps Compliance's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Sharps Compliance Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NasdaqCM:SMED Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-12-31 49.79 1.02 13.14
2019-09-30 47.62 0.83 12.49
2019-06-30 44.31 0.21 12.00
2019-03-31 42.05 -0.42 11.71
2018-12-31 42.03 -0.05 11.61
2018-09-30 40.75 -0.68 11.47
2018-06-30 40.14 -0.67 11.17
2018-03-31 40.59 0.04 11.18
2017-12-31 39.75 0.13 11.17
2017-09-30 38.34 -0.25 11.25
2017-06-30 38.19 -1.29 11.52
2017-03-31 36.70 -1.64 11.57
2016-12-31 34.76 -2.02 11.49
2016-09-30 35.05 -1.17 11.13
2016-06-30 33.38 0.01 10.62
2016-03-31 33.50 1.09 10.09
2015-12-31 33.02 1.32 9.79
2015-09-30 31.72 1.45 9.67
2015-06-30 30.90 1.16 9.50
2015-03-31 29.01 1.51 9.49
2014-12-31 28.39 1.39 9.31
2014-09-30 27.34 0.76 9.24
2014-06-30 26.57 0.96 9.10
2014-03-31 24.72 -1.38 8.82
2013-12-31 24.58 -1.40 8.75
2013-09-30 22.65 -1.95 8.42
2013-06-30 21.53 -2.71 8.42

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Sharps Compliance has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • Sharps Compliance used its assets less efficiently than the US Healthcare industry average last year based on Return on Assets.
  • Sharps Compliance has become profitable over the past 3 years. This is considered to be a significant improvement in its use of capital (Return on Capital Employed).
X
Past performance checks
We assess Sharps Compliance's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Healthcare industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Sharps Compliance has a total score of 1/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

SMED Health

 How is Sharps Compliance's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Sharps Compliance's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Sharps Compliance is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Sharps Compliance's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Sharps Compliance's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 12.6x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Sharps Compliance Company Filings, last reported 3 months ago.

NasdaqCM:SMED Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-12-31 28.07 1.76 5.33
2019-09-30 26.94 1.60 4.87
2019-06-30 26.13 1.47 4.51
2019-03-31 25.54 1.59 5.18
2018-12-31 26.55 1.72 6.41
2018-09-30 25.68 1.85 5.15
2018-06-30 25.17 2.00 5.16
2018-03-31 25.22 2.15 5.50
2017-12-31 25.86 2.30 5.76
2017-09-30 25.48 2.45 5.16
2017-06-30 25.29 2.60 4.68
2017-03-31 24.60 2.73 5.69
2016-12-31 25.07 2.90 7.23
2016-09-30 25.05 3.17 6.91
2016-06-30 23.84 0.00 12.44
2016-03-31 23.46 0.00 13.45
2015-12-31 24.55 0.00 14.46
2015-09-30 24.22 0.00 15.96
2015-06-30 23.59 0.00 15.16
2015-03-31 22.15 0.00 16.15
2014-12-31 22.73 0.00 16.36
2014-09-30 21.82 0.00 16.14
2014-06-30 21.90 0.00 13.72
2014-03-31 20.14 0.00 14.43
2013-12-31 20.91 0.00 15.28
2013-09-30 21.22 0.00 15.34
2013-06-30 21.07 0.00 15.50
  • Sharps Compliance's level of debt (6.3%) compared to net worth is satisfactory (less than 40%).
  • Unable to establish if Sharps Compliance's debt level has increased without past 5-year debt data.
  • Debt is well covered by operating cash flow (38.3%, greater than 20% of total debt).
  • Interest payments on debt are well covered by earnings (EBIT is 20.2x coverage).
X
Financial health checks
We assess Sharps Compliance's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Sharps Compliance has a total score of 5/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

SMED Dividends

 What is Sharps Compliance's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Sharps Compliance dividends.
If you bought $2,000 of Sharps Compliance shares you are expected to receive $0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Sharps Compliance's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Sharps Compliance's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
NasdaqCM:SMED Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 3 Analyst Estimates (S&P Global) See Below
United States of America Healthcare Industry Average Dividend Yield Market Cap Weighted Average of 20 Stocks 1.8%
United States of America Market Average Dividend Yield Market Cap Weighted Average of 1941 Stocks 3.1%
United States of America Minimum Threshold Dividend Yield 10th Percentile 1.1%
United States of America Bottom 25% Dividend Yield 25th Percentile 2%
United States of America Top 25% Dividend Yield 75th Percentile 5.7%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

NasdaqCM:SMED Future Dividends Estimate Data
Date (Data in $) Dividend per Share (annual) Avg. No. Analysts
2024-06-30
2023-06-30
2022-06-30
2021-06-30
2020-06-30
2020-04-04

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Sharps Compliance has not reported any payouts.
  • Unable to verify if Sharps Compliance's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Sharps Compliance's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Sharps Compliance has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Sharps Compliance's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.1%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Sharps Compliance afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Sharps Compliance has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

SMED Management

 What is the CEO of Sharps Compliance's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
David Tusa
COMPENSATION $863,741
AGE 59
TENURE AS CEO 9.6 years
CEO Bio

Mr. David P. Tusa, CPA, has been the President of Sharps Compliance Corp. since June 14, 2010 and as its Chief Executive Officer since September 30, 2010. Mr. Tusa served as the Chief Financial Officer of Sharps Compliance Corp. from March 12, 2003 to June 14, 2010 and as its Corporate Secretary since February 2003. Mr. Tusa also served as an Executive Vice President of Business Development at Sharps Compliance Corp. Mr. Tusa served as Senior Vice President of Sharps Compliance Corp. since February 2003 and served as its Interim Chief Financial Officer from February 12, 2003 to March 12, 2003. He served as an Executive Vice President, Chief Financial Officer and Corporate Secretary at Wilhelmina International, Inc. He served as a Corporate Secretary of Tanisys Technology, Inc. since August 2001. He served as an Executive Vice President, Chief Financial Officer and Corporate Secretary of New Century Equity Holdings Corp. Mr. Tusa joined New Century Equity Holdings Corp. in August 1999. Prior to joining New Century Equity Holdings Corp., he served as an Executive Vice President and Chief Financial Officer of U.S. Legal Support Inc., a provider of litigation support services with over 36 offices in seven states, from September 1997 to August 1999. Prior to this, Mr. Tusa served as Senior Vice President, Finance and Administration and Chief Financial Officer of Serv-Tech Inc., from August 1994 to August 1997. Mr. Tusa held positions of Vice President, Controller of National Convenience Stores and Corporate Controller of CRSS Inc. since April, 1990. Prior to this, Mr. Tusa was with the public accounting and consulting firm of KPMG Peat Marwick since January 1983 and most recently as a Senior Manager. Additionally, Mr. Tusa was with CRSS Inc. a $600 million publicly held diversified services company, from May 1990 to April 1994. He has been Director for Sharps Compliance Corp since November 2010. Mr. Tusa served on the Board of Directors of Tanisys Technology Inc., a developer and marketer of semiconductor testing equipment from August 2001 to March 2003 and served as a Member of its Audit Committee. Mr. Tusa served as a member of the Board of Directors of Princeton, a leading application service provider for electronic and Internet bill presentment and payment solutions from December 2001 to June 2002. Mr. Tusa served as an Advisor to the Board of Directors of Sharps, a provider of medical-related sharps disposal services for certain types of medical sharps (needles, syringes and razors) products from October 2001 to January 2003. He holds a B.B.A. in Accounting from the University of Houston and is a Certified Public Accountant (AICPA).

CEO Compensation
  • David's compensation has increased in line with Sharps Compliance recently becoming profitable.
  • David's remuneration is higher than average for companies of similar size in United States of America.
Management Team Tenure

Average tenure and age of the Sharps Compliance management team in years:

8.9
Average Tenure
54
Average Age
  • The average tenure for the Sharps Compliance management team is over 5 years, this suggests they are a seasoned and experienced team.
Management Team

David Tusa

TITLE
President
COMPENSATION
$864K
AGE
59
TENURE
9.6 yrs

Diana Diaz

TITLE
VP, CFO & Corporate Secretary
COMPENSATION
$341K
AGE
56
TENURE
9.8 yrs

Gregory Davis

TITLE
Vice President of Operations
COMPENSATION
$232K
AGE
52
TENURE
8.9 yrs

Dennis Halligan

TITLE
Vice President of Marketing
COMPENSATION
$144K
AGE
45
TENURE
5.4 yrs

Vic Trevino

TITLE
Vice President of Sales
TENURE
0.3 yrs
Board of Directors Tenure

Average tenure and age of the Sharps Compliance board of directors in years:

9.4
Average Tenure
65
Average Age
  • The tenure for the Sharps Compliance board of directors is about average.
Board of Directors

Sharon Gabrielson

TITLE
Non-Executive Chair of the Board
COMPENSATION
$46K
AGE
58
TENURE
0.8 yrs

David Tusa

TITLE
President
COMPENSATION
$864K
AGE
59
TENURE
9.4 yrs

Parris Holmes

TITLE
Independent Director
COMPENSATION
$84K
AGE
75
TENURE
21.8 yrs

John Dalton

TITLE
Independent Director
COMPENSATION
$85K
AGE
78
TENURE
11.4 yrs

Sue Vogt

TITLE
Independent Director
AGE
65
TENURE
0.6 yrs
Who owns this company?
Recent Insider Trading
  • Sharps Compliance individual insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
10. Mar 20 Sell Parris Holmes Individual 06. Mar 20 06. Mar 20 -8,691 $6.21 $-53,971
09. Mar 20 Sell John Dalton Individual 06. Mar 20 06. Mar 20 -17,000 $6.24 $-105,723
06. Mar 20 Sell Parris Holmes Individual 05. Mar 20 05. Mar 20 -10,000 $6.20 $-62,000
04. Mar 20 Sell David Tusa Individual 02. Mar 20 03. Mar 20 -8,037 $6.43 $-50,953
04. Mar 20 Sell Parris Holmes Individual 02. Mar 20 02. Mar 20 -20,000 $6.36 $-127,200
03. Mar 20 Sell John Dalton Individual 28. Feb 20 02. Mar 20 -69,970 $6.38 $-438,913
02. Mar 20 Sell Gregory Davis Individual 27. Feb 20 27. Feb 20 -4,491 $6.50 $-29,192
23. Oct 19 Buy Norman Pessin Individual 17. Oct 19 22. Oct 19 22,400 $4.33 $94,232
17. Jun 19 Buy Diana Diaz Individual 14. Jun 19 14. Jun 19 1,250 $3.34 $4,175
17. Jun 19 Buy David Tusa Individual 13. Jun 19 13. Jun 19 5,000 $3.30 $16,500
14. Jun 19 Buy Parris Holmes Individual 12. Jun 19 13. Jun 19 40,000 $3.34 $132,429
X
Management checks
We assess Sharps Compliance's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Sharps Compliance has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

SMED News

Simply Wall St News

With A 0.8% Return On Equity, Is Sharps Compliance Corp. (NASDAQ:SMED) A Quality Stock?

Check out our latest analysis for Sharps Compliance How Do You Calculate Return On Equity? … The formula for return on equity is: Return on Equity = Net Profit ÷ Shareholders' Equity Or for Sharps Compliance: 0.8% = US$214k ÷ US$26m (Based on the trailing twelve months to June 2019.) It's easy to understand the 'net profit' part of that equation, but 'shareholders' equity' requires further explanation. … Sharps Compliance's Debt And Its 0.8% ROE Although Sharps Compliance does use a little debt, its debt to equity ratio of just 0.056 is very low.

Simply Wall St -

Sharps Compliance (NASDAQ:SMED) Is Using Debt In A Risky Way

NasdaqCM:SMED Historical Debt, July 19th 2019 How Healthy Is Sharps Compliance's Balance Sheet? … This surplus suggests that Sharps Compliance has a conservative balance sheet, and could probably eliminate its debt without much difficulty. … Sharps Compliance boasts net cash, so it's fair to say it does not have a heavy debt load!

Simply Wall St -

Are Insiders Buying Sharps Compliance Corp. (NASDAQ:SMED) Stock?

View our latest analysis for Sharps Compliance The Last 12 Months Of Insider Transactions At Sharps Compliance In the last twelve months, the biggest single purchase by an insider was when Independent Director Parris Holmes bought US$132k worth of shares at a price of US$3.34 per share. … NasdaqCM:SMED Recent Insider Trading, July 1st 2019 Insiders at Sharps Compliance Have Bought Stock Recently Over the last three months, we've seen significant insider buying at Sharps Compliance. … Insiders likely see value in Sharps Compliance shares, given these transactions (along with notable insider ownership of the company).

Simply Wall St -

Imagine Owning Sharps Compliance (NASDAQ:SMED) And Wondering If The 23% Share Price Slide Is Justified

Check out our latest analysis for Sharps Compliance Sharps Compliance isn't currently profitable, so most analysts would look to revenue growth to get an idea of how fast the underlying business is growing. … In the last half decade, Sharps Compliance saw its revenue increase by 10.0% per year. … Sharps Compliance is not the only stock insiders are buying.

Simply Wall St -

What Kind Of Investor Owns Most Of Sharps Compliance Corp. (NASDAQ:SMED)?

With a market capitalization of US$53m, Sharps Compliance is a small cap stock, so it might not be well known by many institutional investors. … See our latest analysis for Sharps Compliance NasdaqCM:SMED Ownership Summary, June 10th 2019 What Does The Institutional Ownership Tell Us About Sharps Compliance? … As you can see, institutional investors own 21% of Sharps Compliance.

Simply Wall St -

Calculating The Intrinsic Value Of Sharps Compliance Corp. (NASDAQ:SMED)

Where possible we use analyst estimates, but when these aren't available we extrapolate the previous free cash flow (FCF) from the last estimate or reported value. … Generally we assume that a dollar today is more valuable than a dollar in the future, so we need to discount the sum of these future cash flows to arrive at a present value estimate: 10-year free cash flow (FCF) forecast 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 Levered FCF ($, Millions) $0.60 $2.10 $2.30 $2.40 $3.20 $3.53 $3.82 $4.06 $4.28 $4.47 Growth Rate Estimate Source Analyst x1 Analyst x1 Analyst x1 Analyst x1 Analyst x1 Est @ 10.35% Est @ 8.06% Est @ 6.46% Est @ 5.34% Est @ 4.56% Present Value ($, Millions) Discounted @ 7.5% $0.56 $1.82 $1.85 $1.80 $2.23 $2.29 $2.30 $2.28 $2.23 $2.17 Present Value of 10-year Cash Flow (PVCF)= $19.52m "Est" = FCF growth rate estimated by Simply Wall St We now need to calculate the Terminal Value, which accounts for all the future cash flows after this ten year period. … Terminal Value (TV) = FCF2029 × (1 + g) ÷ (r – g) = US$4.5m × (1 + 2.7%) ÷ (7.5% – 2.7%) = US$96m Present Value of Terminal Value (PVTV) = TV / (1 + r)10 = $US$96m ÷ ( 1 + 7.5%)10 = $46.78m The total value, or equity value, is then the sum of the present value of the future cash flows, which in this case is $66.30m.

Simply Wall St -

What Kind Of Shareholder Appears On The Sharps Compliance Corp.'s (NASDAQ:SMED) Shareholder Register?

Generally speaking, as a company grows, institutions will increase their ownership. … Sharps Compliance is a smaller company with a market capitalization of US$61m, so it may still be flying under the radar of many institutional investors. … We can zoom in on the different ownership groups, to learn more about SMED

Simply Wall St -

Calculating The Fair Value Of Sharps Compliance Corp. (NASDAQ:SMED)

by taking the foreast future cash flows of the company and discounting them back to today's value. … discounted cash flows (DCF). … If you want to learn more about discounted cash flow, the basis for my calcs can be read in detail in the Simply Wall St analysis model

Simply Wall St -

How Much Are Sharps Compliance Corp. (NASDAQ:SMED) Insiders Spending On Buying Shares?

So we'll take a look at whether insiders have been buying or selling shares in Sharps Compliance Corp. … But logic dictates you should pay some attention to whether insiders are buying or selling shares. … The Last 12 Months Of Insider Transactions At Sharps Compliance.

Simply Wall St -

Do Insiders Own Lots Of Shares In Sharps Compliance Corp (NASDAQ:SMED)?

Large companies usually have institutions as shareholders, and we usually see insiders owning shares in smaller companies. … Sharps Compliance is not a large company by global standards. … Check out our latest analysis for Sharps Compliance

Simply Wall St -

SMED Company Info

Description

Sharps Compliance Corp. provides medical, pharmaceutical, and hazardous waste management services in the United States. It offers Sharps Recovery System for the containment, transportation, treatment, and tracking of medical waste generated outside the hospital and health care facility settings; TakeAway Recovery System for the treatment of used needles, syringes, and other used healthcare products; Route-Based Pickup Service, which offers medical and hazardous waste pick-up services; and MedSafe, a solution for the safe collection, transportation, and proper disposal of unwanted and expired ultimate-user medications. The company also provides TakeAway Medication Recovery System, a solution that facilitates the proper disposal of unused medications; Black Pail Program for Rx, a solution with minimal segregation for the disposal of various pharmaceuticals; Hazardous Drug Spill Control Kit for the cleanup of chemotherapy and other HD spills; TakeAway Recycle System, a solution for the collection and recycling of single-use medical devices from surgical centers and other healthcare facilities; ComplianceTRAC, a Web-based compliance and training program; and Universal Waste Shipback Systems, a solution for the collection, transportation, and recycling of light bulbs, batteries, and other mercury containing devices. In addition, it offers other solutions, such as TakeAway Environmental Return System, SharpsTracer, Sharps Secure, Needle Disposal System, Complete Needle Collection and Disposal System, Pitch-It IV Poles, Asset Return System, and Spill Kit Recovery System, as well as Sharps MWMS, a medical waste management system. The company serves customers in home health care, retail clinics and immunizing pharmacies, pharmaceutical manufacturers, professional offices, assisted living and long-term care facilities, government, consumers, and commercial markets, as well as distributors. Sharps Compliance Corp. was founded in 1992 and is headquartered in Houston, Texas.

Details
Name: Sharps Compliance Corp.
SMED
Exchange: NasdaqCM
Founded: 1992
$117,821,545
16,228,863
Website: http://www.sharpsinc.com
Address: Sharps Compliance Corp.
9220 Kirby Drive,
Suite 500,
Houston,
Texas, 77054,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
NasdaqCM SMED Common Stock Nasdaq Capital Market US USD 24. Jun 1998
BST ZSC Common Stock Boerse-Stuttgart DE EUR 24. Jun 1998
Number of employees
Current staff
Staff numbers
162
Sharps Compliance employees.
Industry
Health Care Services
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2020/04/04 00:14
End of day share price update: 2020/04/03 00:00
Last estimates confirmation: 2020/03/26
Last earnings filing: 2020/02/04
Last earnings reported: 2019/12/31
Last annual earnings reported: 2019/06/30


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.